MRGPRX2

MRGPRX2 Produktliste

Attribut
Cell (3)Protein (4)
Produktbibliothek
Online (6)In Forschung (1)
Spezies
Human (7)
Etikett
- (6)Flag Tag & Avi Tag (1)
Marker
- (3)Unconjugated (2)Biotin-labeled (1)FITC Labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
CHEK-ATF300	Human	HEK293	Human MRGPRX2 (Luc) HEK293 Reporter Cell	Vorbestellung
CHEK-ATP214	Human	HEK293	HEK293/Human MRGPRX2 Stable Cell Line	In den Warenkorb legen
MR2-H52D3	Human	HEK293	Human MRGPRX2 Full Length Protein, Flag Tag (Nanodisc-pro)	In den Warenkorb legen
MR2-H52P3	Human	HEK293	Human MRGPRX2 Full Length Protein (VLP)	In den Warenkorb legen
MR2-H82D5	Human	HEK293	Biotinylated Human MRGPRX2 Full Length Protein, Flag,Avitag™ (Nanodisc-pro)	In den Warenkorb legen
MR2-HF2D3	Human	HEK293	FITC-Labeled Human MRGPRX2 Full Length Protein, Flag Tag (Nanodisc-pro)	In den Warenkorb legen
SCCHO-ATP215	Human	CHO	CHO/Human MRGPRX2 Stable Cell Line	In den Warenkorb legen

Gesamtmenge7

MRGPRX2 Molekülhintergrund

The protein belongs to the family of G-protein coupled receptors, that are preferentially activated by adenosine and uridine nucleotides. It is moderately expressed in undifferentiated HL60 cells, and is located on both chromosomes X and Y.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Dronabinol(AXIM Biotechnologies)		Phase 3 Clinical	Axim Biotech	Neoplasms; Child Nutrition Disorders; Vomiting; Nausea; Cachexia; Sarcopenia; Anorexia Nervosa	Details
Adezunap	AP-707	Phase 3 Clinical	CannaXan GmbH	Multiple Sclerosis; Accidental Injuries; Low Back Pain; Diabetes Mellitus; Peripheral Nerve Injuries; Diabetic peripheral neuropathy; Back Pain; Neuralgia; Somatoform Disorders; Stroke; Peripheral Nervous System Diseases; Brachial Plexus Neuropathies; Phantom Limb; Pain, Postoperative; Diabetic Neuropathies; Brain Injuries, Traumatic; Chronic Pain; Pain; Paraplegia	Details
Dronabinol（Vertanical）	VER-01	Phase 3 Clinical	Vertanical GmbH	Low Back Pain	Details
cannabidiol (Cardiol Therapeutics)		Phase 3 Clinical	Cardiol Therapeutics Inc	Coronavirus Disease 2019 (COVID-19); Pericarditis; Cardiovascular Diseases; Myocarditis	Details
V-24343	V-24343; ANEB-001	Phase 2 Clinical	Vernalis Plc	Poisoning; Obesity	Details
11C-MePPEP	11C-MePPEP	Phase 2 Clinical	Eli Lilly And Company	Substance-Related Disorders; Obesity	Details
AX-1602	AX-1602	Phase 2 Clinical	Axim Biotech	Psoriasis; Dermatitis, Atopic; Vitiligo	Details
Nimacimab	RYI-018; RYI-028; JNJ-2463	Phase 2 Clinical	Bird Rock Bio Inc	Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency, Chronic; Obesity; Diabetic Gastroparesis	Details
ART-2713	NEO-1940; ART-2713; ART27.13; AZD-1940	Phase 2 Clinical	Astrazeneca Plc, Neomed Inc, Pfizer Inc	Weight Loss; Pain; Anorexia; Cachexia; Low Back Pain	Details
Cannabidiol/hydroxychloroquine	IHL-675A; IHL-675	Phase 2 Clinical	Incannex Healthcare Ltd	Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult	Details
AEF-0217	AEF-0217	Phase 2 Clinical	Aelis Farma	Down Syndrome	Details
Monlunabant	MRI-1891; NN9440–INV-202; INV-202	Phase 2 Clinical	Inversago Pharma Inc	Metabolic Syndrome; Metabolic Diseases; Diabetic Nephropathies; Obesity	Details
IGC-AD1	IGC-AD1	Phase 2 Clinical	University Of South Florida	Anxiety; Depression; Alzheimer Disease; Psychomotor Agitation; Memory Disorders	Details
AEF-0117	AEF-0117	Phase 2 Clinical	National Institute On Drug Abuse, Aelis Farma	Marijuana Abuse	Details
[11C]OMAR	[11C]JHU-75528	Phase 1 Clinical	Johns Hopkins University School Of Medicine	Marijuana Abuse; Schizophrenia	Details
ZYN-001	ZYN-001	Phase 1 Clinical	Zynerba Pharmaceuticals	Neuralgia; Fibromyalgia	Details
Tetrahydrocannabivarin	GWP-42004; THCV; O-4394; DELTA9-THCV; GW-42004	Phase 1 Clinical	Gw Pharmaceuticals Plc	Diabetes Mellitus, Type 2; Hyperglycemia; Metabolic Syndrome; Obesity, Morbid; Hypercholesterolemia; Dyslipidemias	Details
Zevaquenabant	MRI-1867; (S)-MRI-1867; INV-101	Phase 1 Clinical	National Institutes Of Health	Scleroderma, Systemic; Colitis, Ulcerative	Details
TPT0301	TPT-0301; TPT0301	Phase 1 Clinical	Tetra Pharm Technologies ApS	Chronic Pain	Details
INV-347	NN9441; NN-9441; INV-347	Phase 1 Clinical	Inversago Pharma Inc	Obesity	Details
IPI 201（Isosceles Pharmaceuticals Inc ）	IPI-201	Phase 1 Clinical		Pain, Postoperative	Details
GFB-024		Phase 1 Clinical	Takeda Pharma	Kidney Diseases; Endocrine System Diseases; Diabetic Nephropathies; Diabetes Complications; Diabetes Mellitus	Details
DBPR-211		Phase 1 Clinical	National Health Research Institutes	Diabetes Mellitus, Type 2	Details
MP-10X	MP-10X	Clinical	Medipure Holdings	Pain	Details
Cannabidiol/Palmitoylethanolamide	THX-210; SCI–210	Clinical	Therapix Biosciences Ltd	Autism Spectrum Disorder; Diabetic Neuropathies	Details
C20T5	C20T5		Murdoch Childrens Research Institute		Details
C12T12	C12T12		Murdoch Childrens Research Institute		Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Cannabidiol/Dronabinol	THC-5; delta-9-THC/CBD; MPL-001; MPL-005; GW-1000; KL16-012; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT	Approved	Gw Pharmaceuticals	Sativex, Qixleef	Canada	Muscle Spasticity; Neuralgia; Cancer Pain; Chronic Pain; Multiple Sclerosis	null	2005-04-01	Back Pain; Phobia, Social; Neuralgia, Postherpetic; Huntington Disease; Reflex Sympathetic Dystrophy; Tourette Syndrome; Muscle Spasticity; Malnutrition; Sciatica; Acute Pain; Neuromyelitis Optica; Arthritis, Psoriatic; Neuralgia; Dementia; Panic Disorder; Osteoarthritis, Knee; Hepatic Insufficiency; Stress Disorders, Post-Traumatic; Healthy Aging; Hidradenitis Suppurativa; Agoraphobia; Drug Resistant Epilepsy; Renal Insufficiency, Chronic; Social Behavior; Corticobasal degeneration; Cerebral Palsy; Low Back Pain; Neoplasms; Sleep Initiation and Maintenance Disorders; Peripheral Nervous System Diseases; Pain; Chronic Pain; Depression; Depressive Disorder, Major; Marijuana Abuse; Marijuana Use; Spasm; Squamous Cell Carcinoma of Head and Neck; Cancer Pain; Renal Insufficiency; Spinal Cord Injuries; Migraine Disorders; Arthritis, Rheumatoid; Neck Pain; Diabetic Neuropathies; Sleep Wake Disorders; Opioid-Related Disorders; Essential Tremor; Anorexia; Anxiety Disorders; Kidney Diseases; Multiple Sclerosis; Tic Dis	Details
Cannabidiol	AVCN-583601; GLA-015; BTX-1503; BTX-1801; BTX-1702; LYT-310; RAD011; PBX-1308; RAD-011; BRCX-014; RLS-103; GWP-42003; GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; ZYN-002; PTL-101; CHI-902; APH-1501	Approved	Gw Pharmaceuticals Plc	Epidiolex, Epidyolex, Zygel, Cannepil	United States	Epilepsies, Myoclonic; Lennox Gastaut Syndrome	null	2018-06-25	Migraine Disorders; Peripheral Nervous System Diseases; Acne Vulgaris; HIV Infections; Tobacco Smoking; Ovarian Neoplasms; Sleep Initiation and Maintenance Disorders; Facial Pain; Substance-Related Disorders; Marijuana Smoking; Tobacco Use Cessation; Anxiety; Pain; Chronic Pain; Marijuana Use; Seizures; Tuberous Sclerosis; Rett Syndrome; Schizophrenia; Appetitive Behavior; Autism Spectrum Disorder; Marijuana Abuse; Brain Injuries, Traumatic; Depression; Alcoholic Intoxication; Inflammatory Bowel Diseases; Fatty Liver; Child Behavior Disorders; Diabetes Mellitus, Type 2; Spinal Cord Injuries; Sleep Wake Disorders; Anxiety Disorders; Neoplasms; Opioid-Related Disorders; Diabetic Neuropathies; Coronavirus Disease 2019 (COVID-19); Musculoskeletal Pain; Graft vs Host Disease; Blepharospasm; Dyspepsia; Arthritis, Rheumatoid; Psychotic Disorders; Hyperalgesia; Chronic Urticaria; Hoarding Disorder; Bipolar Disorder; Pancreatic Neoplasms; Brain Diseases; Dysmenorrhea; Sturge-Weber Syndrome; Lennox Gastaut Syndrome; Ph	Details